← Back to Search

COVID-19 Self-Testing for Coronavirus Exposure (CloseST Trial)

N/A

Waitlist Available

Led By Robert Gross, MD

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, up to one year

Awards & highlights

CloseST Trial Summary

This trial will test if giving self-tests to close contacts of people with Covid-19 will increase the amount of cases found.

Eligible Conditions

Coronavirus

CloseST Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, up to one year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, up to one year

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, up to one year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of positive contacts

Secondary outcome measures

Number of contacts tested

Number of contacts tested (end of study)

Number of household contacts tested

+2 more

CloseST Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Self-Test kit distributionExperimental Treatment1 Intervention

Participants in the self-test arm receive multiple COVID-19 self-test kits to distribute to their close contacts.

Group II: Test referral distributionActive Control1 Intervention

Participants in the test referral arm receive text messages providing testing information to send to their close contacts.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

COVID-19 self-test

2021

N/A

~810

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Public Health Management CorporationOTHER

16 Previous Clinical Trials

5,317 Total Patients Enrolled

University of PennsylvaniaLead Sponsor

2,002 Previous Clinical Trials

42,880,982 Total Patients Enrolled

Robert Gross, MDPrincipal Investigator - University of Pennsylvania

Elliot Gross A Prof Corp, Southern California Hospital at Culver City

University Of Pennsylvania School Of Medicine (Medical School)

Vet Affairs Medical Ctr-W La (Residency)

3 Previous Clinical Trials

1,032 Total Patients Enrolled

Media Library

COVID-19 test referral Clinical Trial Eligibility Overview. Trial Name: NCT04847479 — N/A

Coronavirus Research Study Groups: Self-Test kit distribution, Test referral distribution

Coronavirus Clinical Trial 2023: COVID-19 test referral Highlights & Side Effects. Trial Name: NCT04847479 — N/A

COVID-19 test referral 2023 Treatment Timeline for Medical Study. Trial Name: NCT04847479 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants being accepted for this research project at present?

"Affirmative. According to the information presented on clinicaltrials.gov, this trial is actively looking for participants and has already enlisted 210 individuals from a single medical facility since its inception on May 6th 2021. It was last revised on June 20th 2022."

Answered by AI

What is the current capacity of this clinical research project?

"Affirmative, the information on clinicaltrials.gov attests that this trial is currently seeking volunteers to participate. The trial was posted for recruitment on May 6th 2021 and most recently updated on June 20th 2022. This study requires 210 patients from a single site."

Answered by AI